SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is capturing significant community attention as users highlight its expanding AI-driven infrastructure and active revenue-generating agents on the Base network. Investors are actively discussing the token's potential for long-term utility-based growth, frequently pointing to recent ecosystem updates and development velocity as reasons to accumulate during price fluctuations.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as institutional interest builds around its Ophthalmic platform and the favorable formulary status of VEVYE, leading to strong community conviction that the company is at a historic inflection point. Investors are closely monitoring record prescription growth and sales force expansion as primary catalysts to drive the stock toward long-term targets.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending due to a major de-risking catalyst as the company finalized a commercial agreement with Allseas to develop and operate its first offshore nodule collection system, with Allseas funding a significant portion of development costs. The community is actively discussing the stock's long-term potential as a critical minerals leader, the implications for upcoming earnings, and recent patterns of institutional accumulation despite ongoing volatility.

Canary XRP ETF - Common Shares of Beneficial Interest

Canary XRP ETF

The XRP ecosystem is experiencing a surge in activity driven by optimism surrounding the CLARITY Act and significant institutional interest in spot ETFs. Investors are actively discussing the potential for increased liquidity, the role of XRP in bridging traditional and digital finance, and the impact of sustained ETF inflows on market supply.

Corgi ETF Trust I. - Corgi Lithography & Semiconductor Photonics ETF

Corgi Lithography & Semiconductor Photonics ETF

Investors are rapidly flocking to the recently launched Corgi Lithography & Semiconductor Photonics ETF due to its exposure to the critical infrastructure enabling AI compute. The community is actively discussing the fund's fast-growing assets under management and its role as a strategic companion to memory-focused ETFs in the semiconductor supply chain.

Volatility Shares Trust - Volatility Shares Trust XRP ETF

XRP ETF

The community is heavily focused on XRP following progress with the CLARITY Act, which seeks to clarify the asset's regulatory status as a digital commodity. Investors are actively discussing the potential impact of this legislative momentum, alongside institutional integration news and the growth of XRP-linked exchange-traded products.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as investors digest the advancement of the CLARITY Act, which seeks to clarify the digital asset's regulatory status, while enthusiasm grows around the increasing institutional adoption fueled by the Bitwise XRP ETF and Ripple's expanding payment infrastructure. Community discussions are heavily focused on navigating current market volatility, analyzing long-term utility for cross-border settlements, and debating the potential impact of legislative developments on future price momentum.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is experiencing significant volatility as investors weigh strong backlog growth and a series of contract wins against a broader sector-wide slump. While the community is actively debating the company's long-term valuation and potential for a breakout, ongoing selling pressure is keeping sentiment cautious despite positive earnings commentary.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is gaining strong market attention as investors weigh its robust cardiovascular growth and recent regulatory approvals against ongoing short-term volatility. The community is actively debating the company's valuation following a series of analyst downgrades, while many long-term bulls continue to view the current price as a strategic accumulation opportunity driven by its dominant position in medical device innovation.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant downward pressure as investors debate the impact of negative insider trading patterns and recent class-action litigation involving data privacy. Despite these concerns, bullish sentiment persists among some community members who point to the company's expanding partnerships with major pharmaceutical firms and continued accumulation by prominent institutional investors as indicators of long-term upside potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston

Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston PR Newswire CAMBRIDGE, Mass., April 27...

Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline

Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline Decoy Therapeutics...

Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026

Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026 Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026 PR Newswire CAMBRIDGE, Mass. and HOUSTON, April 6, 2026 Live video webcast...

Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire CAMBRIDGE, Mass. and HOUSTON, April 2, 2026 CAMBRIDGE, Mass. and HOUSTON, April 2, 2026 /PRNewswire/ --Decoy Therapeutics, Inc...

Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform

Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform Decoy Therapeutics Enters Strategic...

Decoy Therapeutics Announces 1-for-12 Reverse Stock Split

Decoy Therapeutics Announces 1-for-12 Reverse Stock Split Decoy Therapeutics Announces 1-for-12 Reverse Stock Split PR Newswire CAMBRIDGE, Mass., March 5, 2026 CAMBRIDGE, Mass., March 5, 2026...

Decoy Therapeutics Joins Webull Corporate Connect Service Platform

Decoy Therapeutics Joins Webull Corporate Connect Service Platform Decoy Therapeutics Joins Webull Corporate Connect Service Platform PR Newswire CAMBRIDGE, Mass. and HOUSTON, Feb. 11, 2026 - Connect...

Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial

Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial Decoy Therapeutics to Participate in the Corporate Connect Webinar Series...

Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform

Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform Decoy Therapeutics Reaches Global...

Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company was founded by Frederick E. Pierce, Barbara Hibner, Peter Marschel, Michael Lipp, and Jodi Cooper in 2020 and is headquartered in Houston, TX.

DCOY
Decoy Therapeutics Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest DCOY News

DCOYDecoy Therapeutics Inc.